Inhibikase Therapeutics (IQT0) Revenue

1 Followers

Inhibikase Therapeutics Revenue

Inhibikase Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Inhibikase Therapeutics had annual revenue of 0.00 with ― growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

€0

Employees

Market Cap

€255.14M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	―	―	―
Dec 31, 2024	―	-260.50K	-100.00%
Dec 31, 2023	260.50K	137.06K	+111.03%
Mar 31, 2023	123.44K	-2.98M	-96.02%
Mar 31, 2022	3.10M	2.40M	+343.92%
Mar 31, 2021	698.47K	-424.27K	-37.79%
Dec 31, 2019	1.12M	-2.92M	-72.22%
Dec 31, 2018	4.04M	1.98M	+96.07%
Dec 31, 2017	2.06M	―	―